BACKGROUND AND PURPOSE: Alzheimer disease (AD) is accompanied by macroscopic atrophy on volumetric MR imaging. A few studies have also demonstrated reduction in magnetization transfer ratio (MTR), suggesting microstructural changes in remaining brain tissue. This study assessed the value of measuring MTR in addition to volumetric MR in differentiating patients with AD from control subjects. MATERIALS AND METHODS: Volumetric T1-weighted images and 3D MTR maps were obtained from 18 patients with AD and 18 age-matched control subjects. Whole-brain (WB) and total hippocampal (Hc) volumes were measured using semiautomated techniques and adjusted for total intracranial volume. Mean MTR was obtained for WB and in the Hc region. Histogram analysis was performed for WB MTR. Among patients, associations between volumetric and MTR parameters and the Mini-Mental State Examination (MMSE) were explored. RESULTS: Patients with AD had significantly reduced WB volume (P<.0001) and mean WB MTR (P=.002) and Hc volume (P<.0001) and Hc mean MTR (P<.0001) compared with control subjects. Histogram analysis of WB MTR revealed significant reduction in the 25th percentile point in patients with AD (P=.03). Both WB volume and mean MTR were independently associated with case-control status after adjusting for the other using linear regression models. However, measuring Hc mean MTR added no statistically significant discriminatory value over and above Hc volume measurement alone. Of all MR imaging parameters, only WB volume was significantly correlated with MMSE (r=0.47, P=.048). CONCLUSIONS: This study demonstrates the independent reduction of WB volume and mean MTR in AD. This suggests that the 2 parameters reflect complementary aspects of the AD pathologic lesion at macrostructural and microstructural levels.
BACKGROUND AND PURPOSE: Alzheimer disease (AD) is accompanied by macroscopic atrophy on volumetric MR imaging. A few studies have also demonstrated reduction in magnetization transfer ratio (MTR), suggesting microstructural changes in remaining brain tissue. This study assessed the value of measuring MTR in addition to volumetric MR in differentiating patients with AD from control subjects. MATERIALS AND METHODS: Volumetric T1-weighted images and 3D MTR maps were obtained from 18 patients with AD and 18 age-matched control subjects. Whole-brain (WB) and total hippocampal (Hc) volumes were measured using semiautomated techniques and adjusted for total intracranial volume. Mean MTR was obtained for WB and in the Hc region. Histogram analysis was performed for WB MTR. Among patients, associations between volumetric and MTR parameters and the Mini-Mental State Examination (MMSE) were explored. RESULTS: Patients with AD had significantly reduced WB volume (P<.0001) and mean WB MTR (P=.002) and Hc volume (P<.0001) and Hc mean MTR (P<.0001) compared with control subjects. Histogram analysis of WB MTR revealed significant reduction in the 25th percentile point in patients with AD (P=.03). Both WB volume and mean MTR were independently associated with case-control status after adjusting for the other using linear regression models. However, measuring Hc mean MTR added no statistically significant discriminatory value over and above Hc volume measurement alone. Of all MR imaging parameters, only WB volume was significantly correlated with MMSE (r=0.47, P=.048). CONCLUSIONS: This study demonstrates the independent reduction of WB volume and mean MTR in AD. This suggests that the 2 parameters reflect complementary aspects of the AD pathologic lesion at macrostructural and microstructural levels.
Authors: A Convit; M J de Leon; J Golomb; A E George; C Y Tarshish; M Bobinski; W Tsui; S De Santi; J Wegiel; H Wisniewski Journal: Psychiatr Q Date: 1993
Authors: M Bozzali; M Franceschi; A Falini; S Pontesilli; M Cercignani; G Magnani; G Scotti; G Comi; M Filippi Journal: Neurology Date: 2001-09-25 Impact factor: 9.910
Authors: Josephine Barnes; Rachael I Scahill; Richard G Boyes; Chris Frost; Emma B Lewis; Charlotte L Rossor; Martin N Rossor; Nick C Fox Journal: Neuroimage Date: 2004-10 Impact factor: 6.556
Authors: Jonathan M Schott; Nick C Fox; Chris Frost; Rachael I Scahill; John C Janssen; Dennis Chan; Rhian Jenkins; Martin N Rossor Journal: Ann Neurol Date: 2003-02 Impact factor: 10.422
Authors: M Mascalchi; A Ginestroni; V Bessi; N Toschi; S Padiglioni; S Ciulli; C Tessa; M Giannelli; L Bracco; S Diciotti Journal: AJNR Am J Neuroradiol Date: 2013-06-06 Impact factor: 3.825
Authors: Giovanni B Frisoni; Nick C Fox; Clifford R Jack; Philip Scheltens; Paul M Thompson Journal: Nat Rev Neurol Date: 2010-02 Impact factor: 42.937
Authors: Wenna Duan; Parshant Sehrawat; Tony D Zhou; James T Becker; Oscar L Lopez; H Michael Gach; Weiying Dai Journal: J Alzheimers Dis Date: 2022 Impact factor: 4.160
Authors: A Ginestroni; M Battaglini; R Della Nave; M Moretti; C Tessa; M Giannelli; P Caffarra; B Nacmias; V Bessi; S Sorbi; L Bracco; N De Stefano; M Mascalchi Journal: J Neurol Date: 2009-03-01 Impact factor: 4.849
Authors: Stephan Seiler; Lukas Pirpamer; Edith Hofer; Marco Duering; Eric Jouvent; Franz Fazekas; Jean-Francois Mangin; Hugues Chabriat; Martin Dichgans; Stefan Ropele; Reinhold Schmidt Journal: Front Aging Neurosci Date: 2014-09-25 Impact factor: 5.750